hesperetin has been researched along with Carcinoma, Anaplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, C; Schluesener, H | 1 |
| Ayyappa, KA; Krishnan, UM; Mohan, A; Sethuraman, S; Smina, TP | 1 |
| Choi, EJ; Kim, GH | 1 |
1 review(s) available for hesperetin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Health-promoting effects of the citrus flavanone hesperidin.
Topics: Anti-Inflammatory Agents; Antioxidants; Carcinoma; Cardiovascular Diseases; Citrus; Drug Combinations; Hesperidin; Humans; Nervous System Diseases; Randomized Controlled Trials as Topic | 2017 |
2 other study(ies) available for hesperetin and Carcinoma, Anaplastic
| Article | Year |
|---|---|
Hesperetin exerts apoptotic effect on A431 skin carcinoma cells by regulating mitogen activated protein kinases and cyclins.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma; Cell Line, Tumor; Cell Survival; Cyclins; Hesperidin; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Reactive Oxygen Species; Skin Neoplasms | 2015 |
Anti-/pro-apoptotic effects of hesperetin against 7,12-dimetylbenz(a)anthracene-induced alteration in animals.
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Antineoplastic Agents; Apoptosis; Carcinoma; Dose-Response Relationship, Drug; Down-Regulation; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Hesperidin; Mammary Neoplasms, Animal; Mice; Mice, Inbred ICR; Rats; Rats, Sprague-Dawley; Up-Regulation | 2011 |